Abstract 4140: Non-proteolytic regulation of oncogenic transcription factors by deubiquitinases

Abstract Oncogenic transcription factors (TFs) such as ETS2 and TEAD4 are critical regulators of genes driving cancer progression, including those involved in proliferation, survival, and metastasis. Despite their importance, the mechanisms modulating their activity through ubiquitination remain poorly understood. This study investigates deubiquitinases (DUBs) that interact with and regulate ETS2 and TEAD4, aiming to uncover novel insights into their transcriptional control.A DUB sub-library screening identified USP39 and OTUD6A as regulators of ETS2 and TEAD4, respectively. USP39 interacts with ETS2 via their amino-terminal regions, independent of the zinc finger and PNT domains, and deubiquitinates ETS2. This interaction reduces ETS2’s nuclear localization and transcriptional activity without affecting its stability, indicating a negative regulatory role. In contrast, OTUD6A interacts with TEAD4 at its YAP-binding domain and deubiquitinates TEAD4. OTUD6A further enhances TEAD4 transcriptional activity and cofactor interactions, notably by promoting YAP binding. Similar to USP39 and ETS2, OTUD6A does not influence TEAD4 stability but positively regulates its activity.These findings highlight the distinct, non-proteolytic roles of USP39 and OTUD6A in modulating transcriptional activity of ETS2 and TEAD4, respectively. Our findings underscore the functional diversity and opposing regulatory mechanisms of DUBs in oncogenic transcriptional control. Citation Format: Yunsik Choi. Non-proteolytic regulation of oncogenic transcription factors by deubiquitinases [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 4140.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-4140
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4140: Non-proteolytic regulation of oncogenic transcription factors by deubiquitinases

Yun-Sik Choi
Cancer Research
Ubiquitin and proteasome pathways
article

Abstract 4140: Non-proteolytic regulation of oncogenic transcription factors by deubiquitinases

Yun-Sik Choi
article en

Abstract

Abstract Oncogenic transcription factors (TFs) such as ETS2 and TEAD4 are critical regulators of genes driving cancer progression, including those involved in proliferation, survival, and metastasis. Despite their importance, the mechanisms modulating their activity through ubiquitination remain poorly understood. This study investigates deubiquitinases (DUBs) that interact with and regulate ETS2 and TEAD4, aiming to uncover novel insights into their transcriptional control.A DUB sub-library screening identified USP39 and OTUD6A as regulators of ETS2 and TEAD4, respectively. USP39 interacts with ETS2 via their amino-terminal regions, independent of the zinc finger and PNT domains, and deubiquitinates ETS2. This interaction reduces ETS2’s nuclear localization and transcriptional activity without affecting its stability, indicating a negative regulatory role. In contrast, OTUD6A interacts with TEAD4 at its YAP-binding domain and deubiquitinates TEAD4. OTUD6A further enhances TEAD4 transcriptional activity and cofactor interactions, notably by promoting YAP binding. Similar to USP39 and ETS2, OTUD6A does not influence TEAD4 stability but positively regulates its activity.These findings highlight the distinct, non-proteolytic roles of USP39 and OTUD6A in modulating transcriptional activity of ETS2 and TEAD4, respectively. Our findings underscore the functional diversity and opposing regulatory mechanisms of DUBs in oncogenic transcriptional control. Citation Format: Yunsik Choi. Non-proteolytic regulation of oncogenic transcription factors by deubiquitinases [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 4140.

Cancer ResearchVol. 85(8_Supplement_1)
Sogang University (KR)
Openalex Percentile: Top 93%
Ubiquitin and proteasome pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.